[1]
Simpson, E., Eichenfield, L., Gooderham, M., Gonzalez, M.E., Hebert, A., Papp, K., Prajapati, V.H., Krupa, D., Burnett, P., Berk, D. and Higham, R. 2023. Efficacy and Safety of Roflumilast Cream 0.15% in Adults and Children Aged ≥6 Years With Mild to Moderate Atopic Dermatitis in Two Phase 3 Trials (INTEGUMENT-1 and INTEGUMENT-2). SKIN The Journal of Cutaneous Medicine. 7, 4 (Jul. 2023), s220. DOI:https://doi.org/10.25251/skin.7.supp.220.